News
![almirall](https://pharmaphorum.com/wp-content/uploads/2018/08/almirall.jpg)
Almirall signs atopic dermatitis R&D deal with Hitgen
Almirall has signed a new research collaboration with Chinese biotech HitGen, to find potential new oral therapies for moderate to severe atopic dermatitis – otherwise known as eczema.